Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A Boom in Devices for the Hearing Impaired

Executive Summary

Competition is spurring innovation in the hearing aid market and providers are excited at the prospect of adopting new products that can improve on existing treatments. The hottest area at the moment is implantable hearing aid devices. It's not a new concept, but it's one that many believe will command a significant share of the market.

You may also be interested in...

Hearing Aid Industry Poised For Growth

The aging baby boomer population is driving linear growth in the multibillion-dollar hearing aid market, which increased 4.76% in 2014, with 3.1 million units sold in the US alone according to the Hearing Industries Association. To drive further growth and capture market share, hearing aid manufacturers have been catering to boomers, and developing new high-tech hearing aids that are more like wearable health care technology, with improved performance and wireless connectivity to electronic devices.

New Hybrid Hearing Device Expands Treatment Options For People With Ski-Slope Hearing Loss

Cochlear Americas launched the Cochlear Nucleus Hybrid Implant System in the US market in May 2014, a first-of-its kind technology that integrates the functions of a hearing aid and cochlear implant in a single device.

US Markets for Neurostimulation Devices

The market for neurostimulation products in the US was valued at approximately $1.3 billion in 2009 and it hasn't even scratched the surface of its potential. According to "US Markets for Neurostimulation Products," a report published in March by the Medtech Insight division of Elsevier Business Intelligence, this market is projected to grow at a healthy compound annual rate of almost 16%, reaching more than $2.7 billion five years from now.

Related Content


Related Companies

Related Deals

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts